Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 385

1.

Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging.

Valente SA, Levine GM, Silverstein MJ, Rayhanabad JA, Weng-Grumley JG, Ji L, Holmes DR, Sposto R, Sener SF.

Ann Surg Oncol. 2012 Jun;19(6):1825-30. doi: 10.1245/s10434-011-2200-7. Epub 2012 Jan 7.

PMID:
22227922
2.

Preoperative axillary ultrasound and fine-needle aspiration biopsy in the diagnosis of axillary metastases in patients with breast cancer: predictors of accuracy and future implications.

Cools-Lartigue J, Sinclair A, Trabulsi N, Meguerditchian A, Mesurolle B, Fuhrer R, Meterissian S.

Ann Surg Oncol. 2013 Mar;20(3):819-27. doi: 10.1245/s10434-012-2609-7. Epub 2012 Sep 13.

PMID:
22972506
3.

Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.

Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, Nicolò G, Schenone F, Tomei D, Cafiero F.

J Surg Oncol. 2004 Mar;85(3):102-11. Review.

PMID:
14991881
4.

Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.

Hatoum HA, Jamali FR, El-Saghir NS, Musallam KM, Seoud M, Dimassi H, Abbas J, Khalife M, Boulos FI, Tawil AN, Geara FB, Salem Z, Shamseddine AA, Al-Feghali K, Shamseddine AI.

Ann Surg Oncol. 2009 Dec;16(12):3388-95. doi: 10.1245/s10434-009-0653-8.

PMID:
19655200
5.

Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.

Monti S, Galimberti V, Trifiro G, De Cicco C, Peradze N, Brenelli F, Fernandez-Rodriguez J, Rotmensz N, Latronico A, Berrettini A, Mauri M, Machado L, Luini A, Paganelli G.

Ann Surg Oncol. 2007 Oct;14(10):2928-31. Epub 2007 Aug 1.

PMID:
17674108
6.

Predicting axillary sentinel node status in patients with primary breast cancer.

Kolarik D, Pecha V, Skovajsova M, Zahumensky J, Trnkova M, Petruzelka L, Halaska M, Sottner O, Otcenasek M, Kolarova H.

Neoplasma. 2013;60(3):334-42. doi: 10.4149/neo_2013_045.

PMID:
23374005
7.

Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.

White RE, Vezeridis MP, Konstadoulakis M, Cole BF, Wanebo HJ, Bland KI.

J Am Coll Surg. 1996 Dec;183(6):575-82.

PMID:
8957459
8.

Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.

Langer I, Guller U, Viehl CT, Moch H, Wight E, Harder F, Oertli D, Zuber M.

Ann Surg Oncol. 2009 Dec;16(12):3366-74. doi: 10.1245/s10434-009-0660-9. Epub 2009 Sep 4.

PMID:
19760047
9.

Axillary staging prior to neoadjuvant chemotherapy for breast cancer: predictors of recurrence.

Kilbride KE, Lee MC, Nees AV, Cimmino VM, Diehl KM, Sabel MS, Hayes DF, Schott AF, Kleer CG, Chang AE, Newman LA.

Ann Surg Oncol. 2008 Nov;15(11):3252-8. doi: 10.1245/s10434-008-0136-3. Epub 2008 Sep 11.

PMID:
18784961
10.

Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy.

Cohen LF, Breslin TM, Kuerer HM, Ross MI, Hunt KK, Sahin AA.

Am J Surg Pathol. 2000 Sep;24(9):1266-72.

PMID:
10976701
11.

Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes.

Fein DA, Fowble BL, Hanlon AL, Hooks MA, Hoffman JP, Sigurdson ER, Jardines LA, Eisenberg BL.

J Surg Oncol. 1997 May;65(1):34-9.

PMID:
9179265
12.

Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.

Kiluk JV, Ly QP, Santillan AA, Meade T, Ramos D, Reintgen DS, Dessureault S, Davis M, Shamehdi C, Cox CE.

Ann Surg Oncol. 2010 Feb;17(2):552-7. doi: 10.1245/s10434-009-0800-2.

PMID:
19957043
13.

High intersystem variability for the prediction of additional axillary non-sentinel lymph node involvement in individual patients with sentinel node-positive breast cancer.

van den Hoven I, Kuijt GP, Voogd AC, Roumen RM.

Ann Surg Oncol. 2012 Jun;19(6):1841-9. doi: 10.1245/s10434-011-2169-2. Epub 2011 Dec 30.

PMID:
22207045
14.

High rate of solitary sentinel node metastases identification by fluorescence-guided lymphatic imaging in breast cancer.

Hirche C, Mohr Z, Kneif S, Murawa D, Hünerbein M.

J Surg Oncol. 2012 Feb;105(2):162-6. doi: 10.1002/jso.22075. Epub 2011 Aug 22.

PMID:
21882198
15.

Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma.

Durak MG, Akansu B, Akin MM, Sevınç AI, Koçdor MA, Saydam S, Harmancioğlu O, Ellıdokuz H, Bekış R, Canda T.

Turk Patoloji Derg. 2011;27(3):189-95. doi: 10.5146/tjpath.2011.01074.

16.

Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients.

Croshaw R, Shapiro-Wright H, Svensson E, Erb K, Julian T.

Ann Surg Oncol. 2011 Oct;18(11):3160-3. doi: 10.1245/s10434-011-1919-5. Epub 2011 Sep 27.

PMID:
21947594
17.

Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma.

Krishnamurthy S, Sneige N, Bedi DG, Edieken BS, Fornage BD, Kuerer HM, Singletary SE, Hunt KK.

Cancer. 2002 Sep 1;95(5):982-8.

18.

Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation.

Newman EA, Sabel MS, Nees AV, Schott A, Diehl KM, Cimmino VM, Chang AE, Kleer C, Hayes DF, Newman LA.

Ann Surg Oncol. 2007 Oct;14(10):2946-52. Epub 2007 May 19.

PMID:
17514407
19.

Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer.

Ueda S, Tsuda H, Asakawa H, Omata J, Fukatsu K, Kondo N, Kondo T, Hama Y, Tamura K, Ishida J, Abe Y, Mochizuki H.

BMC Cancer. 2008 Jun 9;8:165. doi: 10.1186/1471-2407-8-165.

20.

Normal Axillary Ultrasound Excludes Heavy Nodal Disease Burden in Patients with Breast Cancer.

Jackson RS, Mylander C, Rosman M, Andrade R, Sawyer K, Sanders T, Tafra L.

Ann Surg Oncol. 2015 Oct;22(10):3289-95. doi: 10.1245/s10434-015-4717-7. Epub 2015 Jul 30.

PMID:
26224404

Supplemental Content

Support Center